Skip to main content
PATRYS LIMITED logo

PATRYS LIMITED — Investor Relations & Filings

Ticker · PAB ISIN · AU000000PAB9 ASX Professional, scientific and technical activities
Open in API
Filings indexed 916 across all filing types
Latest filing 2025-12-11 Proxy Solicitation & In…
Country AU Australia
Listing ASX PAB

About PATRYS LIMITED

https://patrys.com/

Patrys Limited is a biotechnology company focused on the development of novel antibody-based therapies for the treatment of cancer. The company's primary platform is based on Deoxymabs, a suite of antibodies derived from the 3E10 lupus autoantibody. These antibodies possess the unique capability to cross cell membranes and the blood-brain barrier, targeting the cell nucleus to inhibit DNA damage repair mechanisms. Patrys' lead candidates, PAT-DX1 and PAT-DX3, are engineered to exploit the DNA repair deficiencies inherent in many cancer cells, particularly aggressive forms such as glioblastoma and triple-negative breast cancer. Beyond direct anti-tumor activity, the Deoxymab platform is designed for use in synthetic lethality applications and as a delivery vehicle for therapeutic payloads, including nanoparticles and imaging agents, to target primary and metastatic tumors.

Recent filings

Filing Released Lang Actions
Letter to Shareholders - General Meeting 1 page 132
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter to shareholders regarding an upcoming General Meeting (GM) of Patrys Limited. It provides details about the meeting date, location, and voting instructions. It mentions that the Notice of Meeting and Explanatory Memorandum are available online and will not be physically dispatched unless requested. The document does not contain the Notice itself, nor does it include any financial data or results. It is essentially an announcement about the meeting and how shareholders can access the meeting materials and vote. The document length is short (2664 characters), and it serves as a notification rather than the actual meeting materials or voting results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-12-11 English
Pipeline Expanded with Proprietary Injectable Antipsychotic 8 pages 345.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX & Media Release announcing Patrys Limited's binding agreement to acquire 100% of Reliis Pty Ltd, including detailed terms of the acquisition, strategic rationale, planned activities, capital structure impact, and proposed director appointments. It focuses on a corporate transaction (acquisition) and related capital structure changes such as issuance of shares and performance rights. There is no financial report, earnings data, or regulatory certification. The content is consistent with a Capital/Financing Update (CAP) as it provides information on fundraising, financing activities, and capital structure changes related to the acquisition. The document length is substantial and contains detailed transaction terms, not merely an announcement of a report or a short notice. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-11-25 English
Trading Halt 2 pages 261.4KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Patrys Limited regarding a request for a trading halt pending the release of an announcement about a proposed acquisition. It references ASX Listing Rule 17.1 and states that trading will be halted until the announcement or a specified date. There is no financial data, report content, or detailed analysis present. The document is an announcement about a trading halt related to an upcoming announcement, not the announcement itself or a financial report. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-11-23 English
Changes to Board, Company Secretary and Office Address 3 pages 210.2KB
Board/Management Information Classification · 95% confidence The document is an ASX & Media Release announcing changes in the company's board of directors, specifically the resignation of a Non-Executive Director and appointment of a new Non-Executive Director. It also announces changes in the Company Secretary and the registered office address. There are no financial statements, earnings data, or detailed management discussion. The content focuses on board and management changes, which fits the category of Board/Management Information (MANG). The document length is about 4908 characters, which is sufficient for a detailed announcement but does not contain financial reports or other types of filings. Therefore, the appropriate classification is MANG with high confidence.
2025-11-09 English
Initial Director's Interest Notice 2 pages 225.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held. This is a notification of a director's personal share transactions or interests, consistent with insider trading disclosures. The document length is short and focused solely on director interests, not financial results or management changes. Therefore, it fits the category of Director's Dealing (DIRS).
2025-11-09 English
Final Director's Interest Notice 2 pages 188.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held and interests in contracts. This is a report of personal share transactions and holdings by a company director. The document length is 2471 characters, which is short and focused solely on director's share interests. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades).
2025-11-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.